Literature DB >> 8103579

Can disturbed brain microcirculation cause Alzheimer's disease?

J C de la Torre1, T Mussivand.   

Abstract

Recent ultrastructural studies demonstrate characteristic and extensive angio-architectural distortions of cerebral capillaries in Alzheimer's brains. Alzheimer's disease subjects additionally show reduced cerebral blood flow (CBF), glucose metabolism and oxygen utilization which appear inversely proportional to the disease severity. These findings led us to develop a hypothetical model which appears consistent with the pathogenesis and progression of AD. During ageing, brain capillaries (site of the blood-brain barrier) may undergo progressive degeneration caused by amyloid deposits, thickened basement membrane, cerebral atrophy, reduced vessel elasticity, or genetic predisposition. When these structural abnormalities of the brain microvasculature begin to interfere with basic laws of fluid dynamics, haemorheological compromise will result in cerebral capillary resistance, high blood viscosity, abnormal flow patterns, and changes in shear stress and shear rate in vessel walls. The net effect is chronic 'disturbed' blood flow to the brain that impairs the delivery of essential nutrients, particularly oxygen and glucose, to cerebral neurons. As ischaemic-sensitive neurons lower their oxidative phosphorylation and ATP production to subfunctional levels, they release a diffusible glial mitogen that directly stimulates reactive astrocytosis. These reactive glia differ significantly from normal glia because they proliferate mostly in response to brain injury and can spread to unaffected tissue. It has been suggested that amyloid precursor protein (APP) may be expressed from reactive glia following neuronal injury thus providing the nidus of plaque formation. As brain tissue space is invaded by reactive glia and microglia, neuronal cytoskeletal damage can result in neurofibrillary tangles.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8103579     DOI: 10.1080/01616412.1993.11740127

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  63 in total

Review 1.  The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia.

Authors:  Costantino Iadecola
Journal:  Acta Neuropathol       Date:  2010-07-11       Impact factor: 17.088

Review 2.  The hemo-neural hypothesis: on the role of blood flow in information processing.

Authors:  Christopher I Moore; Rosa Cao
Journal:  J Neurophysiol       Date:  2007-10-03       Impact factor: 2.714

3.  Amyloid precursor protein mediates monocyte adhesion in AD tissue and apoE(-)/(-) mice.

Authors:  Susan A Austin; Colin K Combs
Journal:  Neurobiol Aging       Date:  2008-12-05       Impact factor: 4.673

Review 4.  Mouse models of neurological disorders: a view from the blood-brain barrier.

Authors:  William A Banks
Journal:  Biochim Biophys Acta       Date:  2009-10-29

5.  Effects of Leucocytes in Acute Cerebral Disorders. Proceedings of the 1st International Symposium on this topic. Munich, Federal Republic of Germany, September 26-27, 1994.

Authors: 
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

Review 6.  Drug access to the central nervous system in Alzheimer's disease: preclinical and clinical insights.

Authors:  Dharmini C Mehta; Jennifer L Short; Sarah N Hilmer; Joseph A Nicolazzo
Journal:  Pharm Res       Date:  2014-10-16       Impact factor: 4.200

Review 7.  Getting to the Heart of Alzheimer Disease.

Authors:  Joshua M Tublin; Jeremy M Adelstein; Federica Del Monte; Colin K Combs; Loren E Wold
Journal:  Circ Res       Date:  2019-01-04       Impact factor: 17.367

Review 8.  Type 2 diabetes and risk of cognitive impairment and dementia.

Authors:  Rachel A Whitmer
Journal:  Curr Neurol Neurosci Rep       Date:  2007-09       Impact factor: 5.081

9.  Amyloid-beta induces chemokine secretion and monocyte migration across a human blood--brain barrier model.

Authors:  M Fiala; L Zhang; X Gan; B Sherry; D Taub; M C Graves; S Hama; D Way; M Weinand; M Witte; D Lorton; Y M Kuo; A E Roher
Journal:  Mol Med       Date:  1998-07       Impact factor: 6.354

10.  Microvascular perfusion based on arterial spin labeled perfusion MRI as a measure of vascular risk in Alzheimer's disease.

Authors:  Quan Zhang; Randall B Stafford; Ze Wang; Steven E Arnold; David A Wolk; John A Detre
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.